Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Mutations00:36

Viral Mutations

32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Viral Recombination00:57

Viral Recombination

23.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human milk small extracellular vesicles elicit changes in inflammatory response in infant human intestinal enteroids.

Scientific reports·2026
Same author

Evaluation of serum antibodies as correlates of protection against norovirus infection and disease.

The Journal of infectious diseases·2026
Same author

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Science translational medicine·2026
Same author

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.

Vaccine·2026
Same author

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Vaccine·2026
Same author

Tulane virus protease as a structural surrogate for inhibitor screening of human norovirus proteases.

Journal of virology·2026

Related Experiment Video

Updated: Jun 1, 2025

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

16.6K

Norovirus replication, host interactions and vaccine advances.

B V Venkataram Prasad1,2, Robert L Atmar2,3, Sasirekha Ramani2

  • 1Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA.

Nature Reviews. Microbiology
|January 17, 2025
PubMed
Summary

Human noroviruses (HuNoVs) cause widespread gastroenteritis, with no current vaccines or antivirals. Recent advances in cultivation and structural biology offer new insights into HuNoV strains and host interactions for future therapies.

More Related Videos

Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
07:02

Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry

Published on: April 29, 2020

7.9K
Plaque Assay for Murine Norovirus
10:53

Plaque Assay for Murine Norovirus

Published on: August 22, 2012

54.5K

Related Experiment Videos

Last Updated: Jun 1, 2025

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

16.6K
Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
07:02

Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry

Published on: April 29, 2020

7.9K
Plaque Assay for Murine Norovirus
10:53

Plaque Assay for Murine Norovirus

Published on: August 22, 2012

54.5K

Area of Science:

  • Virology
  • Gastroenterology
  • Immunology

Background:

  • Human noroviruses (HuNoVs) are a primary cause of acute gastroenteritis globally.
  • Significant disease and economic burdens are associated with HuNoV infections.
  • Currently, no approved vaccines or antiviral therapies exist for HuNoV illness.

Purpose of the Study:

  • To review recent breakthroughs in understanding HuNoV biology.
  • To discuss advancements in virus cultivation, structural biology, and metagenomic sequencing.
  • To highlight strain-specific differences and virus-host interactions.

Main Methods:

  • Cultivation of HuNoVs using human intestinal organoid cultures.
  • Application of structural biology techniques and epitope mapping.
  • Utilizing metagenomic sequencing for strain analysis.

Main Results:

  • Breakthroughs in culturing HuNoVs have facilitated deeper biological understanding.
  • Structural biology and epitope mapping reveal unexpected strain-specific differences.
  • New insights into virus-host interactions and host factors influencing pathogenesis have emerged.

Conclusions:

  • Recent scientific advances are crucial for overcoming barriers in HuNoV vaccine and therapy development.
  • Understanding strain-specific variations in structure, replication, and host interactions is key.
  • Future research directions are informed by new knowledge of HuNoV pathogenesis.